The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Collegium Pharmaceutical Inc shares valued at $192,069 were sold by Tupper Colleen on Mar 21 ’25. At $30.03 per share, Tupper Colleen sold 6,396 shares. The insider’s holdings dropped to 156,667 shares worth approximately $4.23 million following the completion of this transaction.
Also, Tupper Colleen sold 1,206 shares, netting a total of over 36,181 in proceeds. Following the sale of shares at $30.00 each, the insider now holds 163,063 shares.
Before that, Dreyer Scott had sold 18,881 shares from its account. In a trade valued at $566,983, the EVP & Chief Commercial Officer traded Collegium Pharmaceutical Inc shares for $30.03 each. Upon closing the transaction, the insider’s holdings decreased to 18,881 shares, worth approximately $2.8 million.
As published in a research note from Needham on January 10, 2025, Collegium Pharmaceutical Inc [COLL] has been rated up from a Hold to a Buy and the price target has been revised to $46. Analysts at H.C. Wainwright upgraded the stock from ‘”a Neutral”‘ to ‘”a Buy”‘ outlook in a report released in late July. As of June 07, 2024, Jefferies has increased its “Hold” rating to a “Buy” for COLL. Earlier on May 10, 2024, Piper Sandler downgraded its rating. Their new recommendation was “a Neutral” for COLL stock which previously was a “an Overweight”.
Analyzing COLL Stock Performance
During the last five days, there has been a surge of approximately 9.49%. Over the course of the year, Collegium Pharmaceutical Inc shares have dropped approximately -5.72%. Shares of the company reached a 52-week high of $34.06 on 01/10/25 and a 52-week low of $23.23 on 04/10/25. A 50-day SMA is recorded $29.05, while a 200-day SMA reached $32.78.
Support And Resistance Levels for Collegium Pharmaceutical Inc (COLL)
According to the 24-hour chart, there is a support level at 26.68, which, if violated, would cause prices to drop to 26.34. In the upper region, resistance lies at 27.56. The next price resistance is at 28.11. RSI (Relative Strength Index) is 43.16 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.41, which suggests the price will decrease in the coming days. Percent R is at 48.18%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
